Abstract:Background: In the treatment of periodontal intrabony defects, the benefits of adding platelet-rich plasma (PRP) to a bone replacement grafting material have not been tested. The purpose of this study was to compare the clinical outcomes obtained by the combination of PRP and a bovine derived xenograft (BDX) to those obtained from the use of the bone replacement graft alone. Methods: Thirteen patients were enrolled in a randomized, split mouth, double-masked clinical trial. Bilateral defects were matched according to their intrasurgical measurements. Qualifying defects had loss of attachment of > or = 6 mm, a radiographically detectable defect of > or = 4 mm, at least two remaining osseous walls, and not primarily related to a furcation involvement. After the hygienic phase, at the baseline examination, probing depth (PD), clinical attachment level (CAL), and recession (REC) were measured. During open flap debridement, the defects were randomly assigned to receive either BDX mixed with PRP or BDX alone. Baseline osseous intrasurgical measurements were obtained. Post-surgical follow-up and maintenance were performed and PD, CAL, and REC were remeasured at 6 months. The mean baseline and 6-month PD, CAL, and REC of the deepest buccal and lingual measurements related to the defect for each group were computed. The change from baseline to 6 months for each parameter measured was calculated. Pre- and postoperative comparisons were made between treatment groups at 6 months. Results: Randomization of the defects resulted in comparable groups (P > or = 0.05). At 6 months, paired t test comparisons within groups showed statistically significant benefits with both treatment modalities (P < or = 0.05). The mean changes (delta) at 6 months for the test and the control groups at the deepest sites were: PD reduction: 3.54 and 2.53 mm; CAL gain: 3.15 and 2.31 mm; and REC: -0.38 and -0.23 mm, respectively. Paired t test comparisons yielded significant differences between treatments for PD and CAL (P < or = 0.05). Conclusion: In this 6-month clinical trial, the addition of a high concentration of autologous platelets to a bovine derived xenograft to treat intrabony defects significantly improved their clinical periodontal response.

Clinical Study of BMP Compound Materialin the Treatment of Periodontal Intrabony Defects

Clinical Evaluation of Periodontal Intrabony Defects Treated with a Reconstituted Bovine Porous Bone Mineral Containing Bone Morphogenetic Proteins

Combination of Bone Morphogenetic Protein with Technique of Guide Tissue Regeneration in the Repair of Periodontal Bone Defects

Clinical study of combination of bone morphogenetic protein complex and collagen membrane in the treatment of periodontal tissues defects

The Effect of Concentrated Growth Factors in the Treatment of Periodontal Intrabony Defects.

Effect of platelet-rich plasma in the treatment of periodontal intrabony defects in humans

Treatment of Periodontal Intrabony Defects Using Bovine Porous Bone Mineral and Guided Tissue Regeneration With/without Platelet-Rich Fibrin: A Randomized Controlled Clinical Trial.

[Evaluation of the efficacy of combined application of concentrated growth factors in ridge preservation of teeth with severe periodontitis]

Bone Morphogenetic Protein Complex Combined with Guided Tissue Regeneration in the Treatment of Periodontal Defects: An experimental study

Quantification of growth factors in advanced platelet-rich fibrin and concentrated growth factors and their clinical efficiency as adjunctive to the GTR procedure in periodontal intrabony defects

Clinical and Radiographic Evaluation of Bio-Oss Granules and Bio-Oss Collagen in the Treatment of Periodontal Intrabony Defects: a Retrospective Cohort Study

[Combination Therapy of Periodontal Intrabony Defects with Demineralized Freeze-Dried Bone Powder and Platelet-Rich Plasma].

The use of enamel matrix derivative alone versus in combination with bone grafts to treat patients with periodontal intrabony defects: a meta-analysis.

The Effect of Xenograft and Platelet-Rich Plasma in the Surgical Management of Intrabony Defects in Periodontitis Patients: A Systematic Review

Clinical effectiveness of autologous platelet-rich plasma and Peptide-enhanced bone graft in the treatment of intrabony defects

Low-Dose Rhbmp2/7 Heterodimer to Reconstruct Peri-Implant Bone Defects: A Micro-Ct Evaluation

Periodontal regeneration using bone morphogenetic protein 2 incorporated biomimetic calcium phosphate in conjunction with barrier membrane: A pre‐clinical study in dogs

Combined use of xenogeneic bone substitute material covered with a native bilayer collagen membrane for alveolar ridge preservation: A randomized controlled clinical trial.

Long-ferm Clinical Outcome after Reconstruction of Periodontal Defects Using a Bovine-Derived Xenograft:a Retrospective Cohort Study

Treatment of intrabony defects with bovine-derived xenograft alone and in combination with platelet-rich plasma: a randomized clinical trial

Clinical applications of concentrated growth factors combined with bone substitutes for alveolar ridge preservation in maxillary molar area: a randomized controlled trial